Vivelle
NDC Package 0083-2325-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vivelle is a . Marketed by Novartis Pharmaceuticals Corporation, this product is identified by NDC 0083-2325 and is authorized under FDA application NDA020323.

Identification & Billing

NDC Package Code
0083-2325-08
Package Description
8 POUCH in 1 PACKAGE / 1 PATCH, EXTENDED RELEASE in 1 POUCH
Product Code
0083-2325
11-Digit Billing Format
00083232508

Clinical Specifications

Proprietary Name
Vivelle
Dosage Form
-

Regulatory & Marketing

Labeler Name
Novartis Pharmaceuticals Corporation
FDA Application #
NDA020323
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-28-1994
End Marketing Date
12-01-2009
Listing Expiration
12-01-2009
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0083-2325-08 identifies a specific commercial package of 8 pouch in 1 package / 1 patch, extended release in 1 pouch of Vivelle, labeled by Novartis Pharmaceuticals Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Novartis Pharmaceuticals Corporation on October 28, 1994. The current certification is valid through December 01, 2009.

How is this Novartis Pharmaceuticals Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00083232508. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0083-2325-08
11-Digit CMS (5-4-2)
00083-2325-08

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.